MedTrace Logo

The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics

NCT01478776 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-12-03

No results posted yet for this study

Summary

The aim of this study is the comparison between the effects of supplementation with omega-3 or placebo for 10 weeks in type 2 diabetics

Conditions

Interventions

DIETARY_SUPPLEMENT

omega-3

4 cap 1 gr omega-3 per day for 10 weeks

DIETARY_SUPPLEMENT

placebo

patient with type 2 diabetes who receive 4 cap placebo/day for 10 weeks

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-03-31
Completion
2013-09-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01478776 on ClinicalTrials.gov